Pulse Biosciences, Inc.
PLSE- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001625101
In the last 90 days, Pulse Biosciences, Inc. insiders filed 2 open-market purchases and 0 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $297.0M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Pulse Biosciences, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 43 | 50 | +7 |
| Shares | 3.86M | 4.41M | +545.5K (+14.1%) |
| Value | $15.6M | $53.4M | +$37.8M (+242.8%) |
New holders (11)
Institutions that held Pulse Biosciences, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Simplex Trading, LLC | 34,293 | $419.0K | 0.01% |
| Jane Street Group, LLC | 33,578 | $411.0K | 0.00% |
| CWM Advisors, LLC | 31,319 | $383.3K | 0.04% |
| Susquehanna International Group, LLP | 27,535 | $337.0K | 0.00% |
| Marshall Wace, LLP | 26,532 | $324.8K | 0.00% |
| The PNC Financial Services Group, Inc. | 19,789 | $242.2K | 0.00% |
| MetLife Investment Management | 9,105 | $111.4K | 0.00% |
| Deutsche Bank AG | 7,700 | $94.2K | 0.00% |
| LM Advisors LLC | 2,430 | $29.7K | 0.01% |
| Russell Investments Group, Ltd. | 1,403 | $17.2K | 0.00% |
| Metropolitan Life Insurance Co | 988 | $12.1K | 0.00% |
Sold out (4)
Institutions that held Pulse Biosciences, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Renaissance Technologies LLC | 71,500 | $288.0K |
| Millennium Management LLC | 47,754 | $192.4K |
| Levin Capital Strategies, L.P. | 19,939 | $80.4K |
| Squarepoint Ops LLC | 19,524 | $78.7K |